A detailed history of Wetherby Asset Management Inc transactions in Repligen Corp stock. As of the latest transaction made, Wetherby Asset Management Inc holds 1,133 shares of RGEN stock, worth $136,118. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,133
Holding current value
$136,118
% of portfolio
0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$170.78 - $208.42 $193,493 - $236,139
1,133 New
1,133 $208,000
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $163,124 - $261,055
-1,012 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$247.59 - $304.47 $8,665 - $10,656
35 Added 3.58%
1,012 $268,000
Q3 2021

Nov 15, 2021

BUY
$194.77 - $324.21 $190,290 - $316,753
977 New
977 $282,000
Q2 2021

Aug 16, 2021

SELL
$165.87 - $220.95 $176,651 - $235,311
-1,065 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$180.37 - $226.26 $192,094 - $240,966
1,065 New
1,065 $207,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.67B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Wetherby Asset Management Inc Portfolio

Follow Wetherby Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.